IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $66,000 | -59.5% | 1,471 | -48.9% | 0.00% | -66.7% |
Q4 2020 | $163,000 | +91.8% | 2,881 | +60.0% | 0.00% | +50.0% |
Q3 2020 | $85,000 | -93.5% | 1,801 | -91.1% | 0.00% | -93.8% |
Q2 2019 | $1,307,000 | +99.8% | 20,333 | +68.0% | 0.03% | +39.1% |
Q4 2018 | $654,000 | +114.4% | 12,106 | +104.5% | 0.02% | +109.1% |
Q3 2018 | $305,000 | +205.0% | 5,919 | +198.6% | 0.01% | +57.1% |
Q4 2017 | $100,000 | -87.6% | 1,982 | -87.6% | 0.01% | -90.3% |
Q3 2017 | $809,000 | +13.9% | 15,961 | +14.3% | 0.07% | +2.9% |
Q2 2017 | $710,000 | +35.5% | 13,959 | +7.1% | 0.07% | +9.4% |
Q1 2017 | $524,000 | 0.0% | 13,037 | +19.0% | 0.06% | -14.7% |
Q4 2016 | $524,000 | +38.3% | 10,952 | +5.8% | 0.08% | +29.3% |
Q3 2016 | $379,000 | +68.4% | 10,347 | +7.4% | 0.06% | +61.1% |
Q2 2016 | $225,000 | +251.6% | 9,637 | +506.9% | 0.04% | +140.0% |
Q1 2016 | $64,000 | -31.2% | 1,588 | +5.2% | 0.02% | -31.8% |
Q4 2015 | $93,000 | – | 1,509 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |